Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Acta Oncol. 2013 Jun;52(5):886-92. doi: 10.3109/0284186X.2013.773072. Epub 2013 Mar 11.
The use of central venous lines carries a significant risk for serious complications and high economic costs. Lately, the peripherally inserted central venous catheter (PICC) has gained in popularity due to presumed advantages over other central venous lines. The aim of this systematic literature review was to identify scientific evidence justifying the use of PICC.
The literature review was performed according to the principles of Cochrane Collaboration. The electronic literature search included common databases up to March 2011. Only those studies rated as high or moderate quality were used for grading of evidence and conclusions.
The search resulted in 827 abstracts, 48 articles were read in full text, and 11 met the inclusion criteria. None of the articles was classified as high quality and two had moderate quality. The results of these two studies indicate that PICC increases the risk for deep venous thrombosis (DVT), but decreases the risk for catheter occlusion. The quality of scientific evidence behind these conclusions, however, was limited. Due to the lack of studies with sufficiently high quality, questions such as early complications, patient satisfaction and costs could not be answered.
We conclude that although PICCs are frequently used in oncology, scientific evidence supporting any advantage or disadvantage of PICC when comparing PICC with traditional central venous lines is limited, apart from a tendency towards increased risk for DVT and a decreased risk for catheter occlusion with PICC.
中央静脉置管存在发生严重并发症和花费高昂的风险。近年来,由于被认为比其他中央静脉置管具有优势,经外周静脉置入中心静脉导管(PICC)越来越受欢迎。本系统文献回顾旨在确定支持使用 PICC 的科学证据。
文献综述按照 Cochrane 协作组的原则进行。电子文献检索包括截至 2011 年 3 月的常用数据库。仅使用被评为高质量或中质量的研究进行证据分级和结论。
搜索结果产生了 827 篇摘要,阅读全文后有 48 篇,符合纳入标准的有 11 篇。没有一篇文章被归类为高质量,有两篇为中质量。这两项研究的结果表明,PICC 增加了深静脉血栓形成(DVT)的风险,但降低了导管堵塞的风险。然而,这些结论背后的科学证据质量有限。由于缺乏高质量的研究,因此无法回答早期并发症、患者满意度和成本等问题。
我们的结论是,尽管 PICC 在肿瘤学中经常使用,但支持 PICC 相对于传统中央静脉置管的任何优势或劣势的科学证据是有限的,除了 PICC 增加 DVT 风险和降低导管堵塞风险的趋势外。